Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The supplement launches as food and drink manufacturers seek to launch products to support consumers coming to the end of their GLP-1 prescriptions
Novo Nordisk has launched its own telehealth programme for regular-dose semaglutide through its own channels, as well as other providers, for $499 per month, although a partnership with Hims & Hers quickly broke down due to what the company said were "concerns about [] illegal mass compounding and deceptive marketing." Hims & Hers which accused Novo Nordisk of 'anticompetitive' actions is now offering a compounded version at $199 per month.
For those seeking additional compounds, injectable Semaglutide is $189 monthly month-to-month, or from $149/mo on the 6-month plan and injectable Tirzepatide is $289/mo month-to-month, or from $249/mo on the 6-month plan
Plaintiffs will present qualified experts who can explain the growing epidemiological evidence, the biological mechanism connecting GLP-1 drugs to impaired optic nerve blood flow, and why the existing labels failed to give doctors a meaningful warning
